🔎 Trials Near Me

Home › Myelodysplastic Syndromes › Rhode Island › Providence

Myelodysplastic Syndromes clinical trials in Providence, RI

4 studies for Myelodysplastic Syndromes are looking for participants at sites in and around Providence (within about 30 miles). Open a study to see who can join and how to contact the study team.

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

RecruitingPhase 2
  • Rhode Island Hospital, Providence
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT05564390

Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens

RecruitingObservational study
  • Lifespan Cancer Institute, Providence
Up to age 30 · All sexes · Updated Jul 16, 2026 · NCT04968834

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, Providence
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

About Myelodysplastic Syndromes

Myelodysplastic Syndromes (MDS) are rare. They are sometimes found during a routine blood test. Learn symptoms, risk factors, and treatment options.

More about Myelodysplastic Syndromes on MedlinePlus

Myelodysplastic Syndromes trials in other cities

Other studies in Providence

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.